tradingkey.logo
๎™
๎™ผ
tradingkey.logo
๎™

Zoetis Inc

ZTS
116.630USD
-0.080-0.07%
์ข…๊ฐ€ย 03/26, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
58.31B์‹œ๊ฐ€์ด์•ก
19.35P/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ Zoetis Inc ํšŒ์‚ฌ

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Zoetis Inc ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ ZTS
ํšŒ์‚ฌ ์ด๋ฆ„Zoetis Inc
์ƒ์žฅ์ผFeb 01, 2013
CEOPeck (Kristin C)
์ง์› ์ˆ˜13800
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒFeb 01
์ฃผ์†Œ10 Sylvan Way
๋„์‹œPARSIPPANY
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ07054
์ „ํ™”19738227000
์›น์‚ฌ์ดํŠธhttps://www.zoetis.com/
์ข…๋ชฉ ์ฝ”๋“œ ZTS
์ƒ์žฅ์ผFeb 01, 2013
CEOPeck (Kristin C)

Zoetis Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.88K
+10.27%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
-7.15%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
+6.17%
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
+28.11%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.71K
+30.18%
Mr. Keith Sarbaugh
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
2.34K
+12.94%
Mr. Nicholas (Nick) Ashton
Mr. Nicholas (Nick) Ashton
Executive Vice President, President - Global Manufacturing and Supply
Executive Vice President, President - Global Manufacturing and Supply
1.82K
+39.96%
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.88K
+10.27%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
-7.15%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
16.26K
+6.17%
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%

์ˆ˜์ต ๋ถ„์„

ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Jan 6
ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
Parasiticides
564.00M
23.50%
Vaccines
496.00M
20.67%
Dermatology
472.00M
19.67%
Anti-infectives
284.00M
11.83%
Pain and sedation
204.00M
8.50%
๊ธฐํƒ€
380.00M
15.83%
์ง€์—ญ๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
United States
1.32B
55.08%
Other emerging markets
228.00M
9.50%
Other Developed
164.00M
6.83%
Brazil
100.00M
4.17%
Australia
87.00M
3.62%
๊ธฐํƒ€
499.00M
20.79%
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
Parasiticides
564.00M
23.50%
Vaccines
496.00M
20.67%
Dermatology
472.00M
19.67%
Anti-infectives
284.00M
11.83%
Pain and sedation
204.00M
8.50%
๊ธฐํƒ€
380.00M
15.83%

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, Feb 19
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, Feb 19
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Investment Management (US)
4.69%
State Farm Insurance Companies
4.00%
Wellington Management Company, LLP
2.70%
๊ธฐํƒ€
71.71%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
The Vanguard Group, Inc.
11.27%
BlackRock Institutional Trust Company, N.A.
5.63%
State Street Investment Management (US)
4.69%
State Farm Insurance Companies
4.00%
Wellington Management Company, LLP
2.70%
๊ธฐํƒ€
71.71%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Investment Advisor
51.20%
Investment Advisor/Hedge Fund
33.30%
Research Firm
4.13%
Insurance Company
4.08%
Pension Fund
2.94%
Bank and Trust
2.62%
Hedge Fund
1.45%
Sovereign Wealth Fund
1.45%
Individual Investor
0.09%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Jan 21
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Jan 21
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2026Q4
2795
428.61M
99.51%
--
2025Q4
3335
436.13M
98.96%
-14.08M
2025Q3
3275
435.62M
98.29%
-1.39M
2025Q2
3277
434.35M
98.00%
-1.58M
2025Q1
3284
432.42M
97.12%
-4.21M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
The Vanguard Group, Inc.
47.78M
10.84%
+5.68M
+13.48%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
22.80M
5.17%
+144.71K
+0.64%
Sep 30, 2025
State Street Investment Management (US)
19.65M
4.46%
-89.97K
-0.46%
Sep 30, 2025
State Farm Insurance Companies
16.87M
3.83%
+21.40K
+0.13%
Sep 30, 2025
Wellington Management Company, LLP
8.54M
1.94%
-348.26K
-3.92%
Sep 30, 2025
Geode Capital Management, L.L.C.
11.14M
2.53%
+57.14K
+0.52%
Sep 30, 2025
Morgan Stanley Investment Management Ltd. (UK)
7.48M
1.7%
+722.07K
+10.69%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
5.19M
1.18%
+131.36K
+2.60%
Jun 30, 2025
Polen Capital Management, LLC
7.52M
1.71%
-904.12K
-10.74%
Sep 30, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
ProShares Pet Care ETF
9.4%
VanEck Pharmaceutical ETF
9.02%
VanEck Agribusiness ETF
7.81%
iShares U.S. Pharmaceuticals ETF
4.26%
Honeytree US Equity ETF
3.86%
First Trust NASDAQ Pharmaceuticals ETF
3.58%
Polen Capital Global Growth ETF
3.35%
State Street SPDR S&P Pharmaceuticals ETF
2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
2.47%
Themes US R&D Champions ETF
1.96%
๋” ๋ณด๊ธฐ
ProShares Pet Care ETF
๋น„์œจ9.4%
VanEck Pharmaceutical ETF
๋น„์œจ9.02%
VanEck Agribusiness ETF
๋น„์œจ7.81%
iShares U.S. Pharmaceuticals ETF
๋น„์œจ4.26%
Honeytree US Equity ETF
๋น„์œจ3.86%
First Trust NASDAQ Pharmaceuticals ETF
๋น„์œจ3.58%
Polen Capital Global Growth ETF
๋น„์œจ3.35%
State Street SPDR S&P Pharmaceuticals ETF
๋น„์œจ2.51%
AAM Sawgrass US Large Cap Quality Growth ETF
๋น„์œจ2.47%
Themes US R&D Champions ETF
๋น„์œจ1.96%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 2.56B USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
Feb 05, 2026
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Jun 02, 2026 going ex on Apr 20, 2026
Apr 20, 2026
Jun 02, 2026
Apr 20, 2026
Dec 11, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.53 paid on Mar 03, 2026 going ex on Jan 20, 2026
Jan 20, 2026
Mar 03, 2026
Jan 20, 2026
Oct 09, 2025
ZTS.NB Final Cash Dividend of gross USD 0.5 paid on Dec 02, 2025 going ex on Oct 31, 2025
Oct 31, 2025
Dec 02, 2025
Oct 31, 2025
May 21, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Sep 03, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Sep 03, 2025
Jul 18, 2025
Feb 06, 2025
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Jun 03, 2025 going ex on Apr 21, 2025
Apr 21, 2025
Jun 03, 2025
Apr 21, 2025
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
๋” ๋ณด๊ธฐ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
KeyAI
๎™